Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Dovetail Genomics Launches Genome Assembly Service with Twist on Hi-C Method

    Oct 20, 2015, 08:20 AM by Michael Croft
    Bio-IT World | Several research groups have reported that the Hi-C technique, developed to study the 3D architecture of chromosomes, can be repurposed to assemble genomes de novo. Now, Dovetail Genomics has taken the next step with a service promising high-contiguity genomes with standard, short-read Illumina sequencers.
    Full story
  • Japan’s Agency for Medical Research and Development, AMED, Selects Certara’s Phoenix WinNonlin Software to Assess New Drug Candidates

    Oct 20, 2015, 08:19 AM by Michael Croft
    PRINCETON, NJ - Oct 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Japan’s new Agency for Medical Research and Development (AMED) has selected Certara’s Phoenix® WinNonlin® software for pharmacokinetic/pharmacodynamic (PK/PD) modeling and non-compartmental analysis of new drug candidates
    Full story
  • SyMyco Announces Expansion in St. Louis

    Oct 19, 2015, 14:10 PM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Oct 19, 2015 - Today, SyMyco, a joint venture between Symbiotic Sciences based in New Delhi, India and Mycorrhizal Applications (MA), based in Grants Pass, OR, announced it is expanding its U
    Full story
  • Richard F. Heck Chemist Who Revolutionized Drug Development Dies at 84

    Oct 16, 2015, 10:49 AM by Michael Croft
    The New York Times | Dr. Heck shared the 2010 Nobel Prize in Chemistry for creating techniques to synthesize complex carbon molecules that are now used to make drugs, electronics and other products.
    Full story
  • The cloud changes IT culture demands new tech skills

    Oct 15, 2015, 10:45 AM by Michael Croft
    Computerworld | Moving to the Cloud is changing more than just data location. It's changing everything about the skills IT workers need to do their jobs and what those jobs entail.
    Full story
  • 23andMe Caps a Year of Recovery with a $115 Million Funding Round

    Oct 14, 2015, 16:45 PM by Michael Croft
    Forbes | With a drug discovery business, an FDA-cleared test, and a new valuation at over $1 billions, 23andMe is once again on the upswing, writes Matthew Herper.
    Full story
  • The Social Face of Genetics at the American Society of Human Genetics Meeting

    Oct 14, 2015, 13:30 PM by Michael Croft
    Bio-IT World | The annual meeting of the ASHG convened last week in Baltimore, in the midst of a new Precision Medicine Initiative that aims to collect one million patients' genomes and medical records into a national cohort. As NIH Director Francis Collins spoke about the possibilities and social responsibilities of that project, ASHG President Neil Risch reflected on past and ongoing misuses of genetics, and a panel of science journalists considered how scientists can best engage the public, build trust, and help non-professionals wrangle with the real-world implications of new discoveries.
    Full story
  • Elizabeth Parrish CEO of BioViva Claims to Undergo Anti-Aging Therapy

    Oct 14, 2015, 09:39 AM by Michael Croft
    MIT Technology Review | An American woman claims she is the first to undergo gene therapy to reverse aging. Judge for yourself.
    Full story
  • Certara Joins EU-ToxRisk – An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

    Oct 12, 2015, 09:35 AM by Michael Croft
    PRINCETON, NJ - Oct 12, 2015 - An international consortium of 39 partner organizations will be funded by the European Commission to work on the integration of new concepts for regulatory chemical safety assessment
    Full story
  • Drug Development is More than Life Science

    Oct 12, 2015, 05:07 AM by Michael Croft
    BERLIN, GERMANY - Oct 12, 2015 - Dr. Anna Baran is Chief Medical Officer at KCR and in this strategic role she has developed a complex viewpoint on the challenges her position entails for a CROx
    Full story
  • New Products and Announcements at the American Society of Human Genetics Meeting

    Oct 9, 2015, 14:25 PM by Michael Croft
    Bio-IT World | Companies including Illumina, Complete Genomics, Pacific Biosciences, Invitae, QIAGEN, and DNAnexus gathered this week at the annual meeting of the American Society of Human Genetics in Baltimore to show off their latest products and services.
    Full story
  • Amazon wants companies to get onto its cloud using new services

    Oct 9, 2015, 10:04 AM by Michael Croft
    Computerworld | Amazon launched a handful of new services all aimed at getting companies onto its cloud platform Wednesday, including a new ruggedized box for shipping data to the cloud provider.
    Full story
  • Estonia Is Embracing Personalized Medicine With Its DNA Biobank

    Oct 9, 2015, 09:41 AM by Michael Croft
    The Atlantic | The country's genetic biobank is still in its earliest stages, but the government hopes to one day have enough donors to totally overhaul its health-care system.
    Full story
  • GENALICE Launches Population Calling Analysis Module

    Oct 8, 2015, 12:00 PM by Michael Croft
    Bio-IT World In a live webinar today, GENALICE launched the Population Calling analysis module to their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite. In partnership with Mount Sinai Hospital, Amazon Web Services, and Intel, GENALICE processed the whole genomes of 800 patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), an Alzheimer’s disease cohort during the webinar.
    Full story
  • City of Hope Turns to PFS Clinical to Mitigate Regulatory and Financial Risk with Clinical Research Coverage Analysis and Budget Standardization

    Oct 7, 2015, 14:30 PM by Michael Croft
    MIDDLETON, WI - Oct 7, 2015 - PFS Clinical, which offers turnkey administrative solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by City of Hope to provide Coverage Analysis (CA) to ensure its clinical research trials remain compliant with complex Medicare billing regulations
    Full story
  • Smart pills transforming the diagnostics and healthcare market

    Oct 7, 2015, 02:54 AM by Michael Croft
    PORTLAND, OR, UNITED STATES - Oct 7, 2015 - Smart pills are ingestible medical devices consisting of elements such as sensors, cameras, patches and trackers that help in better diagnostics and monitoring
    Full story
  • GSK Updates on Social Media Tracking

    Oct 6, 2015, 10:00 AM by Michael Croft
    MobiHealthNews | GlaxoSmithKline and Epidemico won a 2015 Bio-IT World Best Practices award last year for ProjectCRAWL, an effort to survey social media to alert GSK to adverse events. Yesterday, GSK's director of pharmacovigilance gave an update on how the pharma is using Epidemico's data.
    Full story
  • BC Platforms Launches Personalized Precision Medicine Initiative with the University of Colorado Anschutz Medical Campus

    Oct 6, 2015, 03:32 AM by Michael Croft
    HELSINKI, FINLAND - Oct 6, 2015 - BC Platforms, a world leader in genomic data management solutions, today announced that the University of Colorado Anschutz Medical Campus will use the company’s world-leading, comprehensive data management program to support  the launch of the university’s new personalized medicine initiative aiming at translating community genomics into individual well-being
    Full story
  • With Cleversafe buy IBM zeroes in on unstructured data

    Oct 5, 2015, 21:18 PM by Michael Croft
    Computerworld | IBM will acquire object-based storage vendor Cleversafe in a move to bolster its cloud business unit with more flexibility and simplified management options in the hybrid cloud, it announced on Monday.
    Full story
  • Can the New Google Have a Long and Productive Life?

    Oct 2, 2015, 10:19 AM by Michael Croft
    MIT Technology Review | To truly change the world, Google's new holding company will need something that has eluded many previous industrial labs: an effective commercialization strategy.
    Full story
  • «
  • 351
  • 352
  • 353
  • 354
  • 355
  • 356
  • 357
  • 358
  • 359 (current)
  • 360
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy